Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Qual Lett Healthc Lead ; 11(3): 26-7, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10351587

RESUMO

A Wisconsin physician has set up detailed information sheets for nearly 1,500 patients, sending them home with a summary of their medications, allergies, treatment history and more. The informal summary has proven popular not only as a patient education tool, but as an aid to emergency personnel in case of accident or sudden illness, he says.


Assuntos
Controle de Formulários e Registros , Prontuários Médicos , Educação de Pacientes como Assunto , Prescrições de Medicamentos , Serviços Médicos de Emergência , Humanos , Anamnese , Erros de Medicação/prevenção & controle , Pessoa de Meia-Idade , Wisconsin
2.
Contraception ; 26(3): 229-43, 1982 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-6217028

RESUMO

A triphasic, combined oral contraceptive containing 30 - 40 - 30 micrograms ethinyloestradiol (EE), and 50 - 75 - 125 micrograms levonorgestrel was compared with a fixed dose combination containing 30 micrograms EE and 150 micrograms desogestrel in a randomized multicentre trial in 193/199 women and 1 063/1 073 cycles, respectively. The duration of the trial was six months. Eleven centres in Denmark, Sweden, and Norway participated. Contraceptive reliability, bleeding control and side effects were evaluated. Influence on serum sex hormone binding globulin (SHBG) and transcortin was assayed as well as lipid metabolism. Three pregnancies occurred in the group using the triphasic regimen but none in the fixed dose regimen. Two of the three pregnancies were considered drug failures and the third a possible interaction. Possible reasons for the triphasic contraceptive failure are discussed with special reference to a British report on eight pregnancies. Bleeding control appeared to be equally good for the two preparations. However, the number of cycles with spotting, breakthrough bleeding and missed withdrawal bleeding were above the levels reported earlier on the triphasic regimen. About 80 per cent of the women completed the planned six months on either combination. Side effects were generally mild and in accordance with earlier reports on low dose oral contraceptives. Metabolically the triphasic levonorgestrel combination increased SHBG 100 per cent versus 200 per cent for the fixed desogestrel combination. Transcortin rose about 98 and 110 per cent, respectively. Both preparations induced similar changes in the levels of lipids and lipoproteins with the exception of a significant increase in the arachidonic content of cholesterol during treatment with the desogestrel-containing preparation.


Assuntos
Proteínas Sanguíneas/metabolismo , Anticoncepcionais Orais Combinados/administração & dosagem , Anticoncepcionais Orais/administração & dosagem , Lipídeos/sangue , Adolescente , Adulto , Ensaios Clínicos como Assunto , Dinamarca , Desogestrel , Relação Dose-Resposta a Droga , Etinilestradiol/administração & dosagem , Ácidos Graxos/sangue , Feminino , Humanos , Levanogestrel , Lipoproteínas/sangue , Norgestrel/administração & dosagem , Norpregnenos/administração & dosagem , Noruega , Gravidez , Globulina de Ligação a Hormônio Sexual/metabolismo , Suécia , Transcortina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...